MedPath

An English/Spanish Mobile Augmented Reality Pain Assessment App for Hispanic/Latino Pediatric Cancer Patients

Early Phase 1
Active, not recruiting
Conditions
Pain
Pediatric Cancer
Interventions
Device: AR Pain assessment
Registration Number
NCT06635434
Lead Sponsor
ALTality, Inc.
Brief Summary

In this SBIR, ALTality, Inc. ("SpellBound") will assess the feasibility of a dual English/Spanish language augmented reality(AR)-enabled tool for assessing inpatient postoperative pain/nausea/vomiting in Hispanic/Latino children and adolescents with cancer in collaboration with bilingual Spanish-speaking anesthesiologists at the MD Anderson Cancer Center. If successful, the AR app will be an immediately implementable and commercially viable method of providing Hispanic/Latino pediatric cancer patients with limited English proficiency an adjunctive tool to overcome infrastructural barriers to receiving translation services in acute care settings that put them at higher risk of under and/or overtreatment of pain by prescription opioids and future prescription opioid dependency and misuse, at no cost to them or their families.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
16
Inclusion Criteria
  • ages 7-17 years old
  • child able to provide assent, and a legal guardian able to provide informed consent
  • current diagnosis of pediatric cancer
  • undergoing surgery for cancer treatment requiring postoperative inpatient hospitalization
  • prescribed or expected to be prescribed opioids during inpatient perioperative period
  • sufficient mental capacity to comprehend and interact with the game in English or Spanish.
Exclusion Criteria
  • the inability to play with the SpellBound app from English or Spanish instructions
  • daily opioid use within 30 days prior to surgery
  • any concerns from the treatment team.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Augmented reality-enabled pain assessment deployed on a mobileAR Pain assessmentAge-stratified (age 7-11 and age 12-17 years old) augmented reality app to evaluate for pain and opioid-related adverse events with equivalent English and Spanish text, audio, and narration
Primary Outcome Measures
NameTimeMethod
Primary; Percent of enrolled patients who activated/used the app during the PACU stayimmediately after the intervention/procedure/surgery

Feasibility measured as activation/usage of the app recorded by the device ID for each patient

Secondary Outcome Measures
NameTimeMethod
Total time spent playing on the AR app during the PACU stayimmediately after the intervention/procedure/surgery

Length of time (minutes) of app usage recorded by the device ID for each patient

Recorded responses about pain assessment from the appimmediately after the intervention/procedure/surgery

Pain scale score in English or Spanish through the app

Recorded responses about nausea/vomit assessment from the appimmediately after the intervention/procedure/surgery

Baxter animated retching scale score in English or Spanish through the app

Inpatient opioid consumptionimmediately after the intervention/procedure/surgery

Calculated as morphine equivalent dose of all opioids given

Length of stayimmediately after the intervention/procedure/surgery

Total time (minutes) spent in the PACU after surgery

Quality of life surveyimmediately after the intervention/procedure/surgery

PedsQL survey administered to child and/or adult caregiver stratified by age

Rate of opioid prescriptionimmediately after the intervention/procedure/surgery

The percentage of patients with opioid prescriptions at the time of discharge from the electronic health record

Patient/caregiver satisfaction surveyimmediately after the intervention/procedure/surgery

Asked to the patient/caregiver by the study team - 1) How satisfied were you with regards to your pain management in PACU?, 2) How satisfied were you with regards to your nausea management in PACU?, 3) How satisfied were you with the use of the AR app to help assess your pain and nausea?

Trial Locations

Locations (1)

MD Anderson Cancer Center

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath